#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary alveolar haemorrhage Lymphangioma Pleomorphic liposarcoma B-cell type acute leukaemia Primary biliary cholangitis Hepatic cirrhosis Undifferentiated sarcoma Neuroblastoma recurrent Epilepsy with myoclonic-atonic seizures Cutaneous lupus erythematosus Marginal zone lymphoma recurrent Univentricular heart Depression Small intestine adenocarcinoma B precursor type acute leukaemia More trials…

    Learn about Rare Diseases

    CADASIL – Life with Disease Fabry’s disease – Life with Disease Bronchiolitis obliterans syndrome – Diagnostics Hereditary angioedema – Diagnostics Netherton’s syndrome – Treatment Hairy cell leukaemia Fabry’s disease – Diagnostics Activated PI3 kinase delta syndrome Leiomyosarcoma metastatic – Trials in Disease Congenital hypotransferrinaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olopatadine Hydrochloride Glepaglutide ADS-019 Filgrastim Infliximab Thiamine Hydrochloride Atropine Sulfate Erdafitinib DCC-3084 Abiraterone Acetate Df6002 Indacaterol Acetate Andexanet Alfa Decitabine Human Albumin Solution Acetylcholine Chloride Cannabidiol Dermatophagoides Pteronyssinus HEMOPEXIN, HUMAN Tinlarebant More therapies…

    Learn about Your Condition

    Follicular lymphoma stage IV Alcohol abuse Peritoneal abscess Thermal burn Electronic cigarette user Gender dysphoria Rhabdomyosarcoma Pulmonary tuberculosis Large cell lung cancer Spermatocele Cervix carcinoma stage IV Papilloma viral infection Ewing's sarcoma Epileptic encephalopathy Congenital aplastic anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 2

    Not recruiting

    2 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain

  • Study of Remternetug for Patients with Early Alzheimer’s Disease at Risk for Cognitive and Functional Decline

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • LY3372993
    Spain

  • Study on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • VHB937
    Belgium Denmark Finland France Germany Ireland +5

  • Study on the Safety and Effectiveness of TolDec and Immunotherapy for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS
    Spain

  • Study on the Effects of AT-007 for Patients Aged 16-55 with Sorbitol Dehydrogenase Deficiency

    Not recruiting

    4 1
    Investigated Diseases:
    • Neuropathy peripheral
    Investigated Drugs:
    • GOVORESTAT
    Czechia Italy

  • Study on the Effects of Metformin on Cognitive Function in Patients with Huntington’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • Metformin Hydrochloride
    Spain
Previous Page
1 … 92 93 94 95 96 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!